APOA1 and cancer: A large meta‐analysis of randomized controlled trials indicated that for every 10 mg/dL increase in the plasma HDL‐C level, the risk of cancer incidence is reduced by 36%.5 In addition, in numerous cancer cases, the HDL‐C level has been observed to be positively associated with the overall survival rate.5, 6, 7, 8 Apolipoprotein A‐I (ApoA‐I),9, 10, 11 the predominant protein in HDL‐C, has also been observed to be positively related to survival.